A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis-Reference-Cited by-同舟云学术

A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis

Published:2010-03 Issue:3 Volume:62 Page:427-436
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Bissonnette Robert,Papp Kim,Maari Catherine,Yao Yihong,Robbie Gabriel,White Wendy I.,Le Chenxiong,White Barbara

Publisher

Elsevier BV

Subject

Dermatology

Reference30 articles.

1. Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?;Krueger;J Am Acad Dermatol,2000

2. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey;Krueger;Arch Dermatol,2001

3. Psoriasis: a disease of abnormal keratinocytes proliferation induced by T lymphocytes;Valdimarrsson;Immunol Today,1986

4. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis;Gottlieb;Nat Med,1995

5. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial;Mease;Lancet,2000

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reevaluating the role of interferon‐beta in psoriasis pathogenesis: A registry‐based self‐controlled study;The Journal of Dermatology;2024-06-11

2. “Input/output cytokines” in epidermal keratinocytes and the involvement in inflammatory skin diseases;Frontiers in Immunology;2023-10-10

3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

4. Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis;Frontiers in Immunology;2022-06-28

5. Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases;Biomedicines;2022-06-23